Eden Research Share Discussion Threads

[wan] 13/4/2018 10:12

Indeed I had noted that it got at least a mention, but I think that it could get some focus and thus rise up the agenda somewhat going forwards.

I am also impressed with Eden's extensive IP portfolio, which appears to set them apart and will play an important part in attracting interest.

There appears to be a number of catalysts in the pipeline, so the Chairman's "inflexion point" terminology might prove an insightful remark!

[investingisatrickygame] 13/4/2018 09:54

wan,

Seeds has been alluded to before so could be a big one. I don't know enough about that yet aside of the bit commentary that I have read. However, it is being evaluated according to Eden. Source: slide 16

I think the focus should be more immediate to align with the unexpected outside the RNS channel communications as well as points made by the new Chairman. The communications has, in my opinion, been done for a reason. A company who is so resistant to the same (as Eden has been) is, in my opinion, creating a little noise for a reason, so I expect that noise to be backed up. Potential RNS's

1) Sipcam re 'very far advanced' in regards to micro encapsulation
2) The Chairman in the Prelims mention Eden being at an 'inflexion' point. Whether this is point 1) or something else, I do expect something in relation to this
3) Bayer. It's got to come now the Chairman is on board. In my opinion this will add weight to the business relationship, especially as Bayer know their ex in now firmly ensconsed in Eden. The evaluation has been so long and Eden has said that income will flow from Bayer this year. So an announcement of the same and an order book for 4 products to be sold across the good ol US of A
4) Director buys, specifically Sean Smith and the Chairman, assuming they are not in a protracted closed period

I think any or all of these call be delivered in the near or very near future.

[wan] 13/4/2018 07:28

Personally I don't necessarily see Sipcam's investment/holding in Eden as a precursor to a buyout of Eden, but on the same token it could happen. What it does signify however, is that the technology is very promising, which is indeed why I am invested here!

In particular Eden's Sustaine™ encapsulation technology caught my attention (before the Daily Mail piece). I am also very interested in a perhaps overlooked (by the market) aspect of using Edens technology in seed treatments, which is an area where large players are very active in enthusiastically (if not aggressively) assembling seed coating/treatment technologies.

Generally, Eden's existing and pipeline of products appear to have a very promising future, and as such I would expect a step change in the revenues from such in the not too distant future.

[supersonico] 13/4/2018 07:02

Investing,

I would think they are all targets for Sipcam maybe using the Sustaine TM like the Intel inside model.

Sean smith said 'Continuing this theme, I am looking forward to building speed and positioning Eden to be amongst the leaders in our industry'.

That suggests to me that they thru Sipcam want a good chunk of the big player Tier 1 market. They have a novel more potent product in a high compounding annual growth market. No doubt they will attract the attention of the Big players who are all looking for 'sustainable' technology and are under regulatory pressure.

The Cedroz market segment they are looking to target is $550M so this market looks to be of similar size to me at $539M

[investingisatrickygame] 13/4/2018 00:05

Super,

Good find. Would we think

A) they would all be target clients for Sipcam?

B) they are all potential new clients for Eden?

C) they are all potentially interested in acquiring a stake in Eden or taking out Eden?

At $539 million per annum, purely for the micro encapsulation of pesticides, that is smaller than the market potential for Cedroz at $1.3billion. Am I understanding that correctly?

[supersonico] 12/4/2018 23:02

Microencapsulated Pesticides Market



The microencapsulated pesticides market is estimated to rise at a compound annual growth rate of ~11.5 percent.
The microencapsulated pesticides market is estimated to grow $539.50M by 2022, from $312.50M in 2017, at a compound annual growth rate (CAGR) of ~11.5 percent. The sector is influenced by increase in demand for pesticides that are effective in insect control, limits application costs, and reduces the toxicity risks to environment and human health. High cost of production is one of the main restraints for the increase ot the microencapsulated pesticides market.

Agricultural applications are forecasted to boost the increase of microencapsulated formulations, more than non-agricultural applications, between 2017 and 2022.
Established on the application industry, the agricultural segment is expected to grow at a higher rate during the outlook period. The direct use of non-microencapsulated pesticides may cause losses due to leaching, evaporation, and degradation. Therefore, the microencapsulated pesticides are preferred more in agriculture, as they offer protection to the pesticide molecules from direct contact with the environment.
Insecticides led the industry with the biggest share in 2016.

Insecticides recorded for the biggest market share in the microencapsulated pesticides market in 2016. Globally, the industry research & growth activities and product commercialization trends are more concentrated toward microencapsulated insecticides; therefrom, it recorded for the biggest share in the microencapsulated pesticides market.

Europe (EU) recorded for the biggest market share in 2016.
EU was the biggest microencapsulated pesticides market in 2016. The European Crop Protection Association encourages the use of modern agricultural technologies in sustainable development to protect the human health and the environment. The sector in this area is also estimated to be increasing at the highest compound annual growth rate (CAGR) between 2017 and 2022. It is influenced by the growing ban on the usage of certain harmful pesticide chemicals and its formulations in European countries including France and Germany (DE). Italy (IT), Spain (ES), and the UK are other top countries considered in this industry.

The breakdown of the primaries on the basis of company, description, and area, conducted during the business research study, is like:
• By Company category: Tier I - 20.0 percent; Tier II - 30.0 percent; and Tier III - 50.0 percent
• By Description: C-suite - 15.0 percent; D-Level - 25.0 percent; and Others* - 60.0 percent
• By Area: Asia Pacific (APAC) - 40.0 percent; Europe (EU) - 30.0 percent; Americas - 20.0 percent; and RoW- 10.0 percent
*Others contain sales managers, marketing managers, and product managers.
Note: Tier I: Revenue > $1.0B; Tier II: $500.0M < Revenue < $1.0B; Tier III: Revenue < $500.0M
The overall market for microencapsulated pesticides is leaded by, is monopolized by big players including BASF, Syngenta, Bayer (ETR:BAYN), Monsanto, and FMC Corp (NYSE:FMC). Some of the emerging actors in the microencapsulated pesticides market contain ADAMA, BotanoCap, Arysta LifeScience, McLaughlin Gormley King, GAT Microencapsulation, Belchim, and Reed Pacific.
...............................

[northwick] 12/4/2018 16:57

Looks like MM were again bidding for stock at 11.5p around 2pm. Wonder when the new chairman will buy? He has been in the chair for a few months.

[investingisatrickygame] 12/4/2018 14:14

I should have added in my posts 3732 that in the Chairman's report on the preliminary results he stated in his introduction

"I believe that my years of experience, at both Bayer CropScience and Bayer Animal Health, will enable me to help Eden build on its solid foundations, and become a success story in the large, and increasingly important, industries of crop protection, animal health and personal care."

And in his Commercial review

"Recent commercial activity has given me confidence that Eden is at a positive inflexion point."

Tie the latter in with Sipcam and Eden being "very far advanced" and I think a major RNS could be on its way.

Take the former statement and the Sustaine stand alone technology use could breathe productivity into Bayer in a number of divisions.....perhaps.

Inflexion point, very far advanced, strategic partner....something is going to break. Will Eden be able to convey the message to the multiple layers of the market in the right way to get the desired result in the share price. Will the value be so significant that the top level of the market, namely institutions, will simply reflect on those numbers and green credentials and go on a buying spree, in the market, in Eden?

[investingisatrickygame] 12/4/2018 10:26

Super,

Let's take that a stage further. Sipcam, a global business and product and solutions provider to the agro-chemical world hxxp://www.sipcam-oxon.com/public/product-sipcam/ is apparently on the cusp of deploying Eden's Sustaine on 20 commercial active ingredients being produced by Sipcam.

Let us assume these are deployed in worldwide products. Let us also reasonably assume this is considered joint product development as per the This is Money/Proactive article. And of course, Eden as it is Sipcam's products,they will have exclusive distribution rights of the same using the benefits of Sustaine.

In my opinion and for what this is worth, the agro-chemical world has to sit up an take serious note that a global player has effectively revitalised up to 20 commercial products to the extent that they may be better performing, less chemical trace and who knows, may even go as far as being exempt from Maximum Residue Levels.

Why is a major agro-chemical company with this apparent ground-breaking natural chemistry not going to make enquiries about the same. Sustaine is, in theory, more valuable than Mevalone, Cedroz and anything else Eden produces via toll manufacturers.

So I pose a few questions. Once the cat is out of the bag (presumably in the very near future as they are 'very far advanced') and the agro-chemical world is aware of this

1) Will Sipcam strengthen their position in Eden via a greater holding, a board placing or something similar. Maybe another related party looking to take a stake in Eden?

2) Will Sipcam look for exclusive right in perpetuity to use this technology on certain products globally or in certain markets globally and if so, what price might that yield for Eden and shareholders

3) Will another agro-chemical company come in and challenge the playing field and seek to disrupt the Sipcam/Eden relationship for their own personal gain?

4) What impact will this have on the soon to be announced deal with Bayer and what Sustaine tech rights would they seek or would they too seek a piece of Eden or all of Eden and sell of the unrequired bits, leveraging the technology for value.

With Eden's share price so dismally low it appears to me that this could be a very real possibility, but whether it happens is another thing. For sure, Eden is unlikely to be this cheap in the market for much longer and could Eden reasonably resist such a bid from such a player, should it come along?

[littlealbatross2] 12/4/2018 10:12

As ever with Eden more patience required but there does seam more than just a glimmer of light at the end of the tunnel.

[investingisatrickygame] 12/4/2018 09:43

Super

Agreed! So if Eden tech is to be authorised for use in 20 other in use conventional pesticides, how is Eden going to price that revenue stream?

Presumably it reduces the chemical footprint making it more satisfactory to Sipcam, farmer and the regulators.

I wonder what the annual revenue stream is of those 20 products? In theory, Eden should make a fortune from these deals and it will be very important for Eden's future to get these first tech deals, structured and priced correctly!

[supersonico] 12/4/2018 08:56

Investing, W-2 S-0

So Sipcam will be looking to sell conventional chemistry with Eden Tech that improves on the current chemistry and potency I assume, into a very very large market dominated by huge corporations.

And that work is 'a high priority' for Sipcam and 'very far advanced'.

It does make the projections look well and truly understated imo

Eden Revenue forecasts for 2018 are £3.1m / 2019 = £4m / 2020 = £5.7m
.................................................
EXPERT 8: Endocrine disrupting pesticides in water



According to the UFC-Que Choisir, two million French people are served by water contaminated by agricultural pollutants. Does the Ministry of Health confirm this figure? "It is quite surprising, but at this time, no reaction from the services of the Ministry.Therefore this figure is neither confirmed nor reversed. (...) If we find more plant protection products, it is first because we are looking much better than before, "says Julien Bigard.
Pesticide sales increase
A data is still implacable. "On average, 66,000 tonnes of pesticides are sold each year in France, which makes us one of the biggest consumers in Europe, according to the Ministry of the Environment, sales have been increasing since 2010, so it will We have to change our habits, the goal is to halve our consumption by 2025. So there is still a lot of work, "commented the journalist.

[northwick] 12/4/2018 08:44

Twice, but haven't it shared it with anyone else.

[attyg] 12/4/2018 08:17

I've watched it once - not shared with anyone

[investingisatrickygame] 12/4/2018 08:11

Super,

How many times have you watched the Proactive video?

How many people have you shared the video with?

Same questions to everyone else.

[investingisatrickygame] 12/4/2018 08:09

Super,

I'm not sure about that. I don't think there's a qualification that Sipcam is using it on other companies pesticides.

From Sipcam's website hxxp://www.sipcam-oxon.com/public/group/#family

From the This is Money/Proactive article

"Joint product development, exclusive distribution rights in different territories, an evaluation of the Eden portfolio and its technology and whether it can improve 20 active ingredients already being produced by Sipcam were just some aspects of the deal."

[supersonico] 11/4/2018 20:59

Sean Smith's discussion about Sipcam (8mins) is very illuminating. They are preparing to not just use Eden Tech to compliment their own products around the world but use it with about 20 conventional pesticide active ingredients and improve their capabilities in ' a variety of different ways', which will mean I assume that Sipcam aim to do deals with every Pesticide company on the planet.

Is that how you folk understand it?

And that work is 'a high priority' for Sipcam and 'very far advanced'.



Nice..

[investingisatrickygame] 11/4/2018 16:56

Super

The Proactive link you provide to the article is the exact same article as first published. Here is the original article from the 3rd April. The only difference is that the first article was content provision by Proactive for the Daily Mail. The 'copy' article likely had a weeks hiatus before Proactive could put it on their website to allow the Daily Mail to get maximum traction.



I wish Eden could deliver explanations as simple as this

"Terpenes are chemicals that come from essential oils and produced by plants to defend themselves but are volatile and can be difficult to control.

Encapsulated using Sustaine, however, terpenes become a naturally occurring pesticide with a slow release mechanism that leaves no residues in the soil, unlike chemical-based pesticides."

Never use jargon unless you explain it immediately you use it!

[supersonico] 11/4/2018 12:02

Of TOPIC.
Some interesting observations around Silver Market from Bill Holter.


............................................
On Topic

Proactive keeping the Eden in the head lines;

"Eden Research starts to bloom as Mevalone sales ratchet up"

[supersonico] 10/4/2018 17:51

Sustainable Palm Oil: Another Step Along the Road



Doubts cloud Kenya’s renewed palm oil ambitions



Palm Oil Market Is Anticipated To Grow To $88 Billion By 2022: New Report By Grand View Research, Inc.



In oil palm farming, Chief Whip Washiali finds solace when politics get hot



Kenya could save billions from palm tree farming, says Kari

[investingisatrickygame] 10/4/2018 16:17

Supersonico said

"(it's good to talk) as to how these associations work with Eden's public image as a ecological responsible/aware company."

Most investors don't even know Eden. Eden still needs to talk about who and what they are, what the problems are and how they solve them. They need to tell their story. When investors understand this and are accepting of it, they will be far more receptive to Eden's ecological credentials and take far more interest in Eden's public image. Hell, they might even invest in Eden!!!

[attyg] 10/4/2018 15:20

I like the way the MMs (boo hisss) have the spread such that buys are marked as sells and we only see a wave of sells today.